2019 Webinar 3: Meeting the Needs of Newborns Affected by Prenatal Substance Exposure - Live Webinar

2019-Webinar-3.jpg
2019-Webinar-3.jpg

2019 Webinar 3: Meeting the Needs of Newborns Affected by Prenatal Substance Exposure - Live Webinar

19.99

June 20, 11:00-12:30 p.m. Pacific, 1:00 - 2:30 p.m. Central, 2:00-3:30 p.m. Eastern

Although opiate use and Neonatal Abstinence Syndrome have grabbed the headlines, the types of substances women use during pregnancy cover a wide span, with opiate use patterns almost fading to insignificance when compared to alcohol, tobacco and marijuana use rates during pregnancy. 

Key questions to be addressed:  How do you assess a newborn’s needs for intervention?  What role does early attachment play in designing a management approach for the infant?  How do you know when it is safe to discharge a newborn from the hospital? Where does the child welfare system fit into the big picture?  What State and Federal laws govern reporting of infants affected by prenatal substance exposure to the child welfare system?  What are the key differences between State and Federal legislation and how do CAPTA and CARA fit into the picture? 

Why this is important:  Protocols and practice related to the care of the prenatally exposed infant vary from hospital to hospital and even within hospitals.  This kind of inconsistency frequently results in inappropriate assessment and treatment approaches, including an overuse of medications to treat infants who would have done well with non-pharmacologic intervention.

Quantity:
Add To Cart

Hosted by Dr. Ira J. Chasnoff

Approximately 75-minutes.

Live Q&A to follow presentation.